InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Pollack Kevin, Director. Officer active across 1 companies, notably Pressure Biosciences INC. Aggregated, 7 disclosures have been published. The latest transaction was filed on 24 June 2022 — J. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€979539 shares@ €1.81560.014% mcap15.4% of flow
Common Stock
SEC:0001493152-22-017976:0·
€978465 shares@ €2.10390.014% mcap15.4% of flow
Common Stock
SEC:0001493152-22-011900:0·
€918409 shares@ €2.24490.013% mcap14.5% of flow
Common Stock
SEC:0001493152-22-005829:0·
€897482 shares@ €1.86010.013% mcap51.5% of flow
Common Stock
SEC:0001493152-21-028975·
€897482 shares@ €1.86010.013% mcap14.1% of flow
Common Stock
SEC:0001493152-21-028975:0·
€843494 shares@ €1.705948.5% of flow
Common Stock
SEC:0001493152-21-013310·
€843494 shares@ €1.70590.012% mcap13.3% of flow
Common Stock
SEC:0001493152-21-013310:0·
7 of 7 declarations
About Pollack Kevin
Kevin Pollack is a Board Member at PRESSURE BIOSCIENCES INC. He plays a key role in the governance of the company, contributing to strategic decision-making and guiding growth initiatives. His experience in the industry allows him to provide essential skills and perspectives for business development. As a board member, he is committed to promoting transparency and accountability within the company.
